Lynn Griffin, PhD, Medical Analyst, Hayes Genetic Test Evaluation

Lynn Griffin is a Medical Analyst with the Genetic Testing Evaluation team. She has been involved in genetic research since her first job in high school through her PhD in Biomedical Sciences and postgraduate work. She’s been with Hayes for a year and especially enjoys delving deep into a diversity of topics.

Recent Posts

FDA’s Guidance for Genetic Testing: What are the implications?

In April of this year, the FDA finalized guidelines on two topics related to genetic testing: (1) how to address clinical validity through the use of databases; and (2) how to address analytical validity for next-generation sequencing (NGS)-based diagnosis of germline diseases. The guidelines make recommendations and outline processes that may increase the speed of innovation and create a more efficient path to market for genetic tests.

Read More

Sign up to receive updates from our blog

Our latest articles

New Call-to-action